Currently, CAMP4 Therapeutics Corp [CAMP] is trading at $9.81, up 65.99%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CAMP shares have gain 109.17% over the last week, with a monthly amount glided 5.26%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Overweight rating on November 05, 2024, and set its price target to $18. On November 05, 2024, JP Morgan initiated with a Overweight rating and assigned a price target of $23 on the stock.
This stock has fluctuated between a low of $4.06 and a high of $12.30 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. CAMP4 Therapeutics Corp [NASDAQ: CAMP] shares were valued at $9.81 at the most recent close of the market. An investor can expect a potential return of 78.39% based on the average CAMP price forecast.
Analyzing the CAMP fundamentals
Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at -0.75%, Pretax Profit Margin comes in at -0.77%, and Net Profit Margin reading is -0.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is 2.81 and Total Capital is -0.48. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.48 points at the first support level, and at 3.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.97, and for the 2nd resistance point, it is at 14.13.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CAMP4 Therapeutics Corp [NASDAQ:CAMP] is 0.47. Also, the Quick Ratio is 0.47, while the Cash Ratio stands at 0.38.
Transactions by insiders
Recent insider trading involved Northpond Ventures II GP, LLC, 10% Owner, that happened on Oct 15 ’24 when 0.76 million shares were purchased. 10% Owner, AH Equity Partners Bio I, L.L. completed a deal on Oct 15 ’24 to buy 0.73 million shares. Meanwhile, 10% Owner Enavate Sciences GP, LLC bought 1.36 million shares on Oct 15 ’24.
